[1] |
Kourbeti IS,Vakis AF,Ziakas P, et al. Infections in patients undergoing crani-otomy: risk factors associated with post-craniotomy meningitis[J]. J Neurosurg, 2015, 122(5): 1113-1119.
|
[2] |
Arabi Y,Memish ZA,Balkhy HH, et al. Ventriculostomy-associated infections: incidence and risk factors[J]. Am J Infect Control,2005, 33(3): 137-143.
|
[3] |
Bhimraj A. Acute community-acquired bacterial meningitis in adults: an evidence-based review[J]. Cleve Clin J Med, 2012, 79(6): 393-400.
|
[4] |
Rebuck JA,Murry KR,Rhoney DH, et al. Infection related to intracranial pressure monitors in adults: analysis of risk factors and antibiotic prophylaxis[J]. J Neurol Neurosurg Psychiatry, 2000, 69(3): 381-384.
|
[5] |
Tamelyt E,Vai ekauskien G,Dagys A, et al. Early blood biomarkers to improve sepsis/bacteremia diagnostics in pediatric emergency settings[J]. Medicina (Kaunas), 2019, 55(4): pii E99.
|
[6] |
Martins EC,Silveira LDF,Viegas K, et al. Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study[J]. Rev Bras Ter Intensiva, 2019, 31(1): 64-70.
|
[7] |
Chen J,Qu X,Li Z, et al. Peak neutrophil-to-lymphocyte ratio correlates with clinical outcomes in patients with severe traumatic brain injury[J]. Neurocrit Care, 2019, 30(2): 334-339.
|
[8] |
Chen W,Yang J,Li B, et al. Neutrophil to lymphocyte ratio as a novel predictor of outcome in patients with severe traumatic brain injury[J]. J Head Trauma Rehabil, 2018, 33(1): E53-E59.
|
[9] |
Corbett JM,Ho KM,Honeybul S. Prognostic significance of abnormal hematological parameters in severe traumatic brain injury requiring decompressive craniectomy[J]. J Neurosurg, 2019, 8: 1-7.
|
[10] |
Xue TC,Zhang L,Xie XY, et al. Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis[J]. PLoS One, 2014, 9(5): e96072.
|
[11] |
Yin Y,Wang J,Wang X, et al. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis[J]. Clinics (Sao Paulo), 2015, 70(7): 524-530.
|
[12] |
Zaragoza J,Caille A,Beneton N, et al. High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma[J]. Br J Dermatol, 2016, 174: 146-151.
|
[13] |
Bagley SJ,Kothari S,Aggarwal C, et al. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer[J]. Lung Cancer, 2017, 106: 1-7.
|
[14] |
Cassidy MR,Wolchok RE,Zheng J, et al. Neutrophil to lymphocyte ratio is associated with outcome during ipilimumab treatment[J]. EBioMedicine, 2017, 18: 56-61.
|
[15] |
Gürol G,Ciftci IH,Terizi HA, et al. Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis?[J]. J Microbiol Biotechnol, 2015, 25(4): 521-525.
|
[16] |
Lattanzi S,Brigo F,Trinka E, et al. Neutrophil-to-lymphocyte ratio in acute cerebral hemorrhage: a system review[J]. Transl Stroke Res, 2019, 10(2): 137-145.
|